Loading this page
Bringing the next page into view.
Blueprint Intelligence / Specialized Pathways / How do I raise a VC fund in Asia-Pacific?
Specialized Pathways
Start with the countries, investor types and structure involved. The region has different fund regimes and programs, with conditions that need their own review.
Asia-Pacific contains distinct fundraising markets and regulatory regimes. Australia’s Early Stage Venture Capital Limited Partnership program sets conditions for its particular treatment. India’s Alternative Investment Fund regime has its own categories and requirements. This guide describes the published rules it checked, then identifies questions for other markets. Work with local advisers on which route applies before treating any one program’s conditions as the rules for the region.
The Australian government describes the Early Stage Venture Capital Limited Partnership programme as helping managers attract pooled capital for new venture funds investing in innovative early-stage businesses. Its published conditions establish the program route; they do not describe the wider market.
Read the fund-size floor as a fundraising constraint rather than a permission. A regime that grants investor tax treatment only above a committed-capital threshold has effectively set the smallest viable fund in that market, and a manager who cannot reach the floor is raising a different kind of vehicle rather than a smaller version of the same one.
The Securities and Exchange Board of India's published guidance on the Alternative Investment Funds Regulations sets out the following. Each item is quoted from that guidance and each cites the regulation it rests on within that document.
Singapore operates a distinct regime for venture capital fund managers, and it is frequently the first jurisdiction a manager raising across Asia-Pacific asks about. This page does not describe it, and the reason is worth stating plainly: three separate pages on the Monetary Authority of Singapore's own site were attempted while this page was researched, and all three returned the Authority's service-unavailable message rather than any content.
A licensing regime is exactly the kind of subject where a page written from memory does damage, since a manager could rely on a condition that has changed. The instruction is therefore to read the Authority's current published criteria directly, or to have counsel do so, before treating Singapore as a route.
The same discipline applies to Japan, Hong Kong, and the Southeast Asian markets, none of which was verified for this page and none of which is characterised here.
Whatever market you start in, these are the variables that change the answer, and each has a jurisdiction-specific response.
The regional tests are about coherence between the structure, the strategy, and the investor base.
It describes two markets from their own published rules and names the others as unverified. It states no fund regime, licensing condition, programme term, or eligibility rule for Singapore, Japan, Hong Kong, or the Southeast Asian markets, because none of those was read when this page was written.
It also states no market figure for fundraising or activity anywhere in the region, and no ticket size or process for any sovereign or institutional investor.
This page is educational and general. It is not legal, tax, accounting, or investment advice. Fund regimes, registration, programme eligibility, and marketing permissions should be settled with counsel in each jurisdiction, and every programme condition should be read in its current published form rather than from this page.
Source check recorded: August 4, 2026.
The date records the source check, not a guarantee that the position is unchanged. Confirm current rules and requirements with the original source and your qualified advisers before relying on them for a decision.
Check your Asia-Pacific plan
Upload one document containing your fundraising plan or your structure summary, and Blueprint will read it against this page's published conditions and flag what is assumed rather than verified.
One PDF or DOCX, up to 15 MiB. Three successful free reads are shared across the library; no account is needed. This is an initial review, not an eligibility decision or a fund rating.
Perspectives by Colibrí Strategies: practical notes for GPs and the LPs who back them.
Opens Substack in a new tab, where you confirm the subscription.
Continue in this pillar
Also relevant
Choose SSBCI, DFI, impact, ESG or DEI. Blueprint separates supported, partial and missing evidence and gives you a prioritized assembly plan.